LOPSL klinikiniai tyrimai Nevada
8 tyrimai dėl LOPSL ieško dalyvių vietose Nevada.
Miestai Nevada
Oficialus tyrimo tekstas (anglų kalba)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Las Vegas
- Research Site, Las Vegas
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Excel Clinical Research - Las Vegas- Site Number : 8400070, Las Vegas
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Henderson Clinical Trials- Site Number : 8400026, Henderson
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07190209A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Las Vegas
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Henderson Clinical Trials, Henderson
Renkami dalyviai2/3 fazė
Amžius nuo 35 iki 80 · Visoms lytims · Atnaujinta 2026-08-31 · NCT07363694eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Henderson
- GSK Investigational Site, Las Vegas
- GSK Investigational Site, Reno
Renkami dalyviai3 fazė
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-07-28 · NCT07177339Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Las Vegas
Renkami dalyviai3 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-04-09 · NCT06961214Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Renown Regional Medical Center, Reno
Renkami dalyviaiStebimasis tyrimas
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2025-08-05 · NCT06122077Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.